Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 369 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Polyzos, Stergios A [Clear All Filters]
Enriched MACK-3 following CHAI and MACK-3 for the noninvasive diagnosis of nonalcoholic steatohepatitis..
Ann Hepatol. 19(5), 579-580.
(2020). Erratum to: Letter to the editor re: Li et al. (2020), 'The potential role of bacteria in pancreatic cancer: A systematic review'..
Carcinogenesis.
(2020). Helicobacter pylori infection as a potential risk factor for multiple sclerosis..
Med Hypotheses. 143, 110135.
(2020). Helicobacter pylori, Sleeve Gastrectomy, and Gastroesophageal Reflux Disease: Is There a Relation?.
Obes Surg.
(2020). Homocysteine in nonalcoholic steatohepatitis: seemingly a paradox revisited..
J Gastrointestin Liver Dis. 29(2), 270-271.
(2020).
(2020). Letter: Helicobacter pylori in proton pump inhibitor-associated biliary disease..
Aliment Pharmacol Ther. 51(2), 313-314.
(2020). Letter: Helicobacter pylori infection and its role in oesophageal adenocarcinoma..
Aliment Pharmacol Ther. 51(11), 1215-1216.
(2020). Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)..
Metabolism. 154318.
(2020).
(2020). National consensus on infection: the next-day challenge..
Ann Gastroenterol. 33(3), 324-325.
(2020). Nonalcoholic fatty liver disease in males with low testosterone concentrations..
Diabetes Metab Syndr. 14(5), 1571-1577.
(2020). Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns..
Metabolism. 104, 154144.
(2020). Potential Impact of Helicobacter pylori Infection on Reflux Disease Sequence: Illuminating the Gap..
J Clin Gastroenterol. 54(2), 200-201.
(2020). Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosis..
Dig Liver Dis. 52(1), 121-123.
(2020).
(2020). Response to letter to the editor of Carcinogenesis by Li et al., 2020..
Carcinogenesis. 41(4), 539-540.
(2020). Rodent models of obesity..
Minerva Endocrinol. 45(3), 243-263.
(2020). Selenium and selenoprotein P in nonalcoholic fatty liver disease..
Hormones (Athens). 19(1), 61-72.
(2020). Similar late effects of a 7-week orthodox religious fasting and a time restricted eating pattern on anthropometric and metabolic profiles of overweight adults..
Int J Food Sci Nutr. 1-11.
(2020).
(2020). Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents..
Expert Opin Pharmacother. 21(3), 247-251.
(2020). Treatment of nonalcoholic fatty liver disease with an anti-osteoporotic medication: A hypothesis on drug repurposing..
Med Hypotheses. 110379.
(2020). Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial..
Medicina (Kaunas). 56(7),
(2020). Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection..
Int J Clin Pract. e13737.
(2020).